Abeona Therapeutics (ABEO) News Today $5.70 +0.07 (+1.24%) (As of 12/20/2024 05:15 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period StockNews.com Upgrades Abeona Therapeutics (NASDAQ:ABEO) to HoldStockNews.com raised shares of Abeona Therapeutics from a "sell" rating to a "hold" rating in a research note on Friday.December 20 at 11:23 PM | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Cut to "Sell" at StockNews.comDecember 15, 2024 | americanbankingnews.comAbeona Therapeutics (NASDAQ:ABEO) Rating Lowered to Sell at StockNews.comStockNews.com cut Abeona Therapeutics from a "hold" rating to a "sell" rating in a research report on Thursday.December 12, 2024 | marketbeat.comAbeona Therapeutics Inc (NASDAQ:ABEO) is Western Standard LLC's 3rd Largest PositionWestern Standard LLC raised its stake in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 7.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,698,097 shares of the biopharmaceutical companyDecember 6, 2024 | marketbeat.comIkarian Capital LLC Reduces Position in Abeona Therapeutics Inc (NASDAQ:ABEO)Ikarian Capital LLC cut its holdings in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 24.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 583,593 shares of the biopharmaceutical coDecember 3, 2024 | marketbeat.comWalleye Capital LLC Trims Holdings in Abeona Therapeutics Inc (NASDAQ:ABEO)Walleye Capital LLC cut its position in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 13.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 861,301 shares of the biopDecember 2, 2024 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Upgraded to Hold at StockNews.comStockNews.com upgraded shares of Abeona Therapeutics from a "sell" rating to a "hold" rating in a research note on Thursday.November 28, 2024 | marketbeat.comWhat is HC Wainwright's Estimate for ABEO FY2024 Earnings?Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Stock analysts at HC Wainwright lifted their FY2024 EPS estimates for Abeona Therapeutics in a report released on Monday, November 25th. HC Wainwright analyst R. Selvaraju now forecasts that the biopharmaceutical company will post earnings perNovember 27, 2024 | marketbeat.comAbeona Therapeutics Inc (NASDAQ:ABEO) Shares Sold by Propel Bio Management LLCPropel Bio Management LLC reduced its position in Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 50.0% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 624,022 shares of the biopharmaceutical company's stock after selling 624,022 sharesNovember 26, 2024 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Given Buy Rating at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $15.00 target price on shares of Abeona Therapeutics in a report on Monday.November 25, 2024 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Raised to "Hold" at StockNews.comStockNews.com raised shares of Abeona Therapeutics from a "sell" rating to a "hold" rating in a research report on Wednesday.November 20, 2024 | marketbeat.comAbeona Therapeutics Inc (ABEO) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...November 16, 2024 | finance.yahoo.comAbeona Therapeutics Reports Q3 2024 Financial HighlightsNovember 16, 2024 | markets.businessinsider.comAbeona Therapeutics expects cash to fund operations into 2026November 14, 2024 | markets.businessinsider.comAbeona Therapeutics Inc.November 14, 2024 | wsj.comAbeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate UpdatesNovember 14, 2024 | globenewswire.comAbeona: FDA To Review Resubmission Of BLA For Pz-cel - Quick FactsNovember 12, 2024 | markets.businessinsider.comAbeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis BullosaNovember 12, 2024 | globenewswire.comRosalind Advisors Inc. Has $11.58 Million Holdings in Abeona Therapeutics Inc (NASDAQ:ABEO)Rosalind Advisors Inc. grew its holdings in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 4.7% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,832,000 shares of the biopharmaceutical company's stock afterNovember 6, 2024 | marketbeat.comAbeona Therapeutics Inc (NASDAQ:ABEO) Stake Lifted by abrdn plcabrdn plc lifted its stake in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 158.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 326,995 shares of the biopharmaceutical company's stock after acqNovember 5, 2024 | marketbeat.comAbeona Therapeutics® Announces Participation in November Investor ConferencesNovember 4, 2024 | globenewswire.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 1, 2024 | globenewswire.comAbeona Therapeutics (NASDAQ:ABEO) Receives "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and set a $15.00 price target on shares of Abeona Therapeutics in a report on Thursday.October 31, 2024 | marketbeat.comAbeona Therapeutics completes Pz-cel BLA resubmission to U.S. FDAOctober 29, 2024 | markets.businessinsider.comAbeona Therapeutics (NASDAQ:ABEO) Stock Rating Reaffirmed by Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and issued a $18.00 price target on shares of Abeona Therapeutics in a research note on Tuesday.October 29, 2024 | marketbeat.comAbeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug AdministrationOctober 29, 2024 | globenewswire.comRosalind Advisors, Inc. Expands Stake in Myomo IncOctober 19, 2024 | finance.yahoo.comAbeona Therapeutics (NASDAQ:ABEO) Share Price Crosses Above 50-Day Moving Average - What's Next?Abeona Therapeutics (NASDAQ:ABEO) Share Price Crosses Above Fifty Day Moving Average - Here's What HappenedOctober 11, 2024 | marketbeat.comAbeona Therapeutics Inc (ABEO) Q2 2024 Earnings Call Highlights: Strong Financial Performance ...October 10, 2024 | finance.yahoo.comAbeona Therapeutics Targets RDEB Market With Promising Pz-cel TherapyOctober 3, 2024 | seekingalpha.comRenaissance Technologies LLC Grows Stake in Abeona Therapeutics Inc (NASDAQ:ABEO)Renaissance Technologies LLC grew its stake in shares of Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) by 581.6% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 503,293 shares of the biopharmaceutical company's stock after buyinOctober 3, 2024 | marketbeat.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 1, 2024 | globenewswire.comAbeona Therapeutics Inc (NASDAQ:ABEO) Sees Significant Drop in Short InterestAbeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) was the recipient of a significant decrease in short interest in September. As of September 15th, there was short interest totalling 2,630,000 shares, a decrease of 7.4% from the August 31st total of 2,840,000 shares. Currently, 6.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 301,300 shares, the short-interest ratio is currently 8.7 days.September 29, 2024 | marketbeat.comAbeona Therapeutics' (ABEO) "Overweight" Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating and set a $18.00 price target on shares of Abeona Therapeutics in a research note on Friday.September 20, 2024 | marketbeat.comSimplify Asset Management Inc. Makes New $1.73 Million Investment in Abeona Therapeutics Inc (NASDAQ:ABEO)Simplify Asset Management Inc. bought a new stake in Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 408,584 shares of the biopharmaceutical company's stock, valued at aSeptember 20, 2024 | marketbeat.comAbeona Therapeutics Inc (NASDAQ:ABEO) Sees Large Decrease in Short InterestAbeona Therapeutics Inc (NASDAQ:ABEO - Get Free Report) was the target of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 2,840,000 shares, a decrease of 6.3% from the August 15th total of 3,030,000 shares. Currently, 7.3% of the shares of the company are sold short. Based on an average trading volume of 348,000 shares, the short-interest ratio is currently 8.2 days.September 18, 2024 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Stock Passes Below 200-Day Moving Average of $5.49Abeona Therapeutics (NASDAQ:ABEO) Shares Pass Below 200-Day Moving Average of $5.49September 18, 2024 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Shares Pass Above Fifty Day Moving Average of $5.08Abeona Therapeutics (NASDAQ:ABEO) Share Price Crosses Above 50-Day Moving Average of $5.08September 10, 2024 | marketbeat.comAbeona Therapeutics® Announces Participation in Upcoming Investor ConferencesSeptember 3, 2024 | globenewswire.comStockNews.com Downgrades Abeona Therapeutics (NASDAQ:ABEO) to SellStockNews.com lowered Abeona Therapeutics from a "hold" rating to a "sell" rating in a research note on Monday.September 2, 2024 | marketbeat.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 2, 2024 | globenewswire.comResearch Analysts Offer Predictions for Abeona Therapeutics Inc's FY2024 Earnings (NASDAQ:ABEO)Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Stock analysts at Zacks Small Cap raised their FY2024 earnings estimates for Abeona Therapeutics in a report released on Wednesday, August 14th. Zacks Small Cap analyst D. Bautz now forecasts that the biopharmaceutical company will earn ($1.33August 19, 2024 | marketbeat.comQ3 2024 Earnings Estimate for Abeona Therapeutics Inc Issued By HC Wainwright (NASDAQ:ABEO)Abeona Therapeutics Inc (NASDAQ:ABEO - Free Report) - Equities researchers at HC Wainwright cut their Q3 2024 earnings per share estimates for shares of Abeona Therapeutics in a research note issued to investors on Wednesday, August 14th. HC Wainwright analyst R. Selvaraju now expects that the biAugust 16, 2024 | marketbeat.comABEO: Type A Meeting with FDA Concluded; BLA Submission on Track for 2H24…August 15, 2024 | msn.comBuy Rating on Abeona Therapeutics Bolstered by Positive Medicare Decisions and FDA Approval ProgressAugust 15, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Abeona Therapeutics (ABEO), Cyclacel Pharmaceuticals (CYCC) and Cardinal Health (CAH)August 15, 2024 | markets.businessinsider.comAbeona Therapeutics (NASDAQ:ABEO) Receives Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $15.00 price target on shares of Abeona Therapeutics in a research report on Wednesday.August 14, 2024 | marketbeat.comAbeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of DirectorsAugust 14, 2024 | globenewswire.comAbeona Therapeutics (NASDAQ:ABEO) Upgraded to "Hold" by StockNews.comStockNews.com upgraded Abeona Therapeutics from a "sell" rating to a "hold" rating in a research note on Tuesday.August 13, 2024 | marketbeat.comAbeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-celAugust 13, 2024 | globenewswire.com Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin ABEO Media Mentions By Week ABEO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABEO News Sentiment▼-0.020.59▲Average Medical News Sentiment ABEO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABEO Articles This Week▼22▲ABEO Articles Average Week Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Collegium Pharmaceutical News Septerna News Zymeworks News Bicara Therapeutics News Gyre Therapeutics News Liquidia News Pacira BioSciences News Phibro Animal Health News Cogent Biosciences News Nuvation Bio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABEO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
